{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "L858R",
          "alt": "R",
          "position": "858"
        },
        "variant_string_id": "EGFR L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "EGFR mutations in the EGFR gene are linked to cancer, suggesting potential pathogenicity.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links EGFR mutations to cancer, indicating a pathogenic connection to Parkinson's. This aligns with the assay aiming to validate EGFR's role in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "EGFR mutations are a known cancer-related gene, suggesting they may not directly relate to Parkinson's pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The assay aims to validate EGFR's function in PD, but cancer is a separate condition. This indicates the assay may not directly model PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "EGFR mutations are not directly linked to Parkinson's pathology; the focus is on PINK1's role in PD.",
          "judgment": "No",
          "reasoning": "The assessment steps indicate the assay's focus is on PINK1's function in PD, not EGFR's. This confirms the assay's relevance to PD pathogenesis.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The EGFR L858R variant is pathogenic, supported by its direct link to Parkinson's pathogenesis and the assay's focus on PINK1's role in PD."
    },
    {
      "variant_id": {
        "Gene": "CFTR",
        "Protein_Change": {
          "ref": "R117H",
          "alt": "H",
          "position": "117"
        },
        "variant_string_id": "CFTR R117H"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "CFTR mutations are linked to respiratory conditions, suggesting potential pathogenicity in PD.",
          "judgment": "Yes",
          "reasoning": "The paper directly connects CFTR mutations to Parkinson's, indicating a pathogenic link. This aligns with the assay aiming to validate CFTR's function in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "CFTR mutations are not directly linked to Parkinson's pathology; the focus is on PINK1's role in PD.",
          "judgment": "No",
          "reasoning": "The assessment steps indicate the assay's focus is on PINK1's function in PD, not CFTR's. This confirms the assay's relevance to PD pathogenesis.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "CFTR mutations are not directly linked to Parkinson's pathology; the focus is on PINK1's role in PD.",
          "judgment": "No",
          "reasoning": "The assessment steps indicate the assay's focus is on PINK1's function in PD, not CFTR's. This confirms the assay's relevance to PD pathogenesis.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The CFTR R117H variant is pathogenic, supported by its direct link to Parkinson's pathogenesis and the assay's focus on PINK1's role in PD."
    }
  ]
}